DCP Capital Partners
DCP sells MFS Technology to Chinese strategic for $460m
DCP Capital Partners has agreed to sell MFS Technology, a manufacturer of customised printed circuit boards (PCB) that has a presence across Asia, to Shenzhen-listed Victory Giant Technology for USD 460m.
DCP agrees carve-out of Cargill's China poultry unit
DCP Capital has agreed to buy the China-based poultry business of US-headquartered food and agriculture corporation Cargill for an undisclosed sum.
DCP backs China expansion by Canadian vitamins brand
DCP Capital has agreed to invest approximately USD 175m to support the China expansion of Jamieson Wellness, a listed Canadian producer of health and wellness products.
DCP hits $2.5b first close on second China fund
DCP Capital has already completed five investments from its second China fund, having completed a first close of USD 2.5bn in January.
Nestle buys into DCP-backed plant-based protein provider
Orgain, a US plant-based nutrition business backed by China’s DCP Capital Partners, has agreed to sell a majority stake to Nestle. The size of the transaction was not disclosed.
PE consortium cuts 51job take-private offer by 28%
A private equity consortium pursuing a take-private of US-listed Chinese online recruitment platform 51job has cut its offer price by 28%, citing deteriorating market conditions, regulatory tightening in China, and the continuing impact of COVID-19.
DCP leads $235m round for China's Datong Insurance
DCP Capital Partners has become the largest institutional shareholder in Datong Insurance Service, one of China’s leading insurance brokerages, after leading a RMB1.5 billion ($235 million) round.
China's Broncus raises $215m in IPO, struggles on HK debut
Broncus Holding Corporation, a China-based manufacturer of medical devices used to treat lung diseases, plunged 12.8% on its Hong Kong trading debut following a HK$1.67 billion ($215 million) IPO.
PE investors agree $5.7b 51job take-private
A consortium led by DCP Capital Partners has finalized terms for a $5.7 billion privatization of US-listed Chinese online recruitment platform 51job.
DCP, Sequoia lead Series B for China's Valgen Medtech
DCP Capital has continued its run of investments in China’s medical devices industry by participating in a Series B funding round for Hangzhou Valgen Medtech.
Ocean Link joins consortium pursuing 51job take-private
DCP Capital Partners has enlarged the consortium seeking to acquire Chinese online recruitment services platform 51job with the addition of Ocean Link Capital and the target company’s CEO.
Deal focus: DCP, KKR milk new dairy opportunity
The private equity firms are backing Adopt A Cow’s combination of high-quality, high-transparency dairy products and its ability to reach young Chinese consumers through non-traditional channels
KKR, DCP back China's Adopt A Cow
KKR and DCP Capital Partners have jointly invested in Adopt A Cow, a China-based dairy farm operator that pursues a direct-to-consumer sales model underpinned by digital tools.
DCP, CPE make $300m China data center play
DCP Capital Partners and CPE – formerly CITIC Private Equity – have led a $300 million investment in Hotwon Group, a Chinese cloud computing infrastructure services provider.
DCP pursues $5.6b take-private of China's 51job
DCP Capital Partners has submitted a take-private offer for Chinese online recruitment services platform 51job that values the company at approximately $5.6 billion.
DCP invests $283m in Chinese diabetes treatment player
DCP Capital Partners has acquired a 9% stake in Tonghua Dongbao Pharmaceutical, a Chinese pharmaceutical company specializing in diabetes treatment, for RMB1.94 billion ($283.7 million).
DCP, Qiming support China medical devices fund
Ascendum Capital Partners, a healthcare investment firm established by DCP Capital, Qiming Venture Partners and Chinese medical devices manufacturer Venus Medtech, is looking to raise $200 million for its debut fund.
Discipline, operations key to PE success in China - DCP's Liu
Private equity investors in China should prioritize discipline on valuations and operational capabilities rather than spend their time worrying about macroeconomic risks, according to David Liu, chairman and founder of DCP Capital.
Fund focus: Old heads, new firm
Just over two years after its founders spun out from KKR, DCP Capital has raised China’s joint-largest first-time fund on record. The firm sees opportunities emerging in a changing commercial environment
DCP closes debut China fund at $2.5b
DCP Capital – a PE firm established by David Liu (pictured) and Julian Wolhardt, who previously held leadership positions with KKR in China – has closed its debut fund with around $2.5 billion in commitments. It comprises a US dollar-denominated tranche...
CDH, DCP to invest $70m in China's Sunpower
DCP Capital Partners, a private equity firm established by the former China heads of KKR, has agreed to jointly invest $70 million alongside CDH Investments in Chinese energy industry supplier Sunpower.
DCP to invest in Chinese heart valve developer
DCP Capital Partners, a private equity firm set up by the former heads of KKR’s China business, has agreed to invest an undisclosed sum in domestic heart valve developer Venus Medtech.
Deal focus: Navis thinks long, goes fast with MFS
Navis Capital Partners sees MFS Technology - the first exit from its seventh fund - as the initial manifestation of a strategy that takes a long-term view on a target industry's development but focuses on rapid implementation of value creation plans